(Q47314419)

English

Analysis of naturally occurring resistance-associated variants to NS3/4A protein inhibitors, NS5A protein inhibitors and NS5B polymerase inhibitors in patients with chronic hepatitis C.

scientific article published on 8 December 2017

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

3 July 2018

http://europepmc.org/abstract/PMC/5885147

Analysis of naturally occurring resistance-associated variants to NS3/4A protein inhibitors, NS5A protein inhibitors and NS5B polymerase inhibitors in patients with chronic hepatitis C. (English)

1 reference

Europe PubMed Central

PMC publication ID

3 July 2018

http://europepmc.org/abstract/PMC/5885147

author name string

Danhui Sun

1

1 reference

Europe PubMed Central

PMC publication ID

3 July 2018

http://europepmc.org/abstract/PMC/5885147

Mingjia Dai

2

1 reference

Europe PubMed Central

PMC publication ID

3 July 2018

http://europepmc.org/abstract/PMC/5885147

Shanshan Shen

3

1 reference

Europe PubMed Central

PMC publication ID

3 July 2018

http://europepmc.org/abstract/PMC/5885147

Chunyang Li

4

1 reference

Europe PubMed Central

PMC publication ID

3 July 2018

http://europepmc.org/abstract/PMC/5885147

Xuebing Yan

5

1 reference

Europe PubMed Central

PMC publication ID

3 July 2018

http://europepmc.org/abstract/PMC/5885147

publication date

8 December 2017

1 reference

Europe PubMed Central

PMC publication ID

3 July 2018

http://europepmc.org/abstract/PMC/5885147

Gene Expression

1 reference

Europe PubMed Central

PMC publication ID

3 July 2018

http://europepmc.org/abstract/PMC/5885147

18

1 reference

Europe PubMed Central

PMC publication ID

3 July 2018

http://europepmc.org/abstract/PMC/5885147

1

1 reference

Europe PubMed Central

PMC publication ID

3 July 2018

http://europepmc.org/abstract/PMC/5885147

63-69

1 reference

Europe PubMed Central

PMC publication ID

3 July 2018

http://europepmc.org/abstract/PMC/5885147

The importance of resistance to direct antiviral drugs in HCV infection in clinical practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885147

3 July 2018

Next generation sequencing of the hepatitis C virus NS5B gene reveals potential novel S282 drug resistance mutations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885147

3 July 2018

In vitro and in vivo antiviral activity and resistance profile of ombitasvir, an inhibitor of hepatitis C virus NS5A.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885147

3 July 2018

Clinical evidence and bioinformatics characterization of potential hepatitis C virus resistance pathways for sofosbuvir

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885147

3 July 2018

Naturally occurring resistance mutations to inhibitors of HCV NS5A region and NS5B polymerase in DAA treatment-naïve patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885147

3 July 2018

Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885147

3 July 2018

Characterization of virologic escape in hepatitis C virus genotype 1b patients treated with the direct-acting antivirals daclatasvir and asunaprevir

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885147

3 July 2018

Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885147

3 July 2018

Hepatitis C virus variants with decreased sensitivity to direct-acting antivirals (DAAs) were rarely observed in DAA-naive patients prior to treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885147

3 July 2018

Prevalence of hepatitis C virus variants resistant to NS3 protease inhibitors or the NS5A inhibitor (BMS-790052) in hepatitis patients with genotype 1b.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885147

3 July 2018

TMC435 for the treatment of chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885147

3 July 2018

Genotype and subtype profiling of PSI-7977 as a nucleotide inhibitor of hepatitis C virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885147

3 July 2018

The HCV NS5B nucleoside and non-nucleoside inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885147

3 July 2018

Directly acting antivirals against hepatitis C virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885147

3 July 2018

EASL Clinical Practice Guidelines: management of hepatitis C virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885147

3 July 2018

Resistance analysis of the hepatitis C virus NS5A inhibitor BMS-790052 in an in vitro replicon system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885147

3 July 2018

In vitro resistance profile of the hepatitis C virus NS3/4A protease inhibitor TMC435.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885147

3 July 2018

Phenotypic Characterization of Resistant Val36 Variants of Hepatitis C Virus NS3-4A Serine Protease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885147

3 July 2018

Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885147

3 July 2018

Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885147

3 July 2018

Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5A replication complex inhibitor BMS-790052 in humans: in vitro and in vivo correlations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5885147

14 August 2018

Identifiers

10.3727/105221617X15100607143377

1 reference

Europe PubMed Central

PMC publication ID

3 July 2018

http://europepmc.org/abstract/PMC/5885147

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

3 July 2018

http://europepmc.org/abstract/PMC/5885147

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

3 July 2018

http://europepmc.org/abstract/PMC/5885147

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47314419&oldid=1290070450"